Fig. 3From: A combined 2-D and 3-D QSAR modeling, molecular docking study, design, and pharmacokinetic profiling of some arylimidamide-azole hybrids as superior L. donovani inhibitorsThe plot of standardized residuals against leverages (William’s plot)Back to article page